Card image cap

Amy Klobuchar's Public Statements on Issue: Drugs

Office:
Page 1 of 5

Date Title
03/23/2024 Klobuchar Statement Following Senate Passage of the Final Bipartisan Legislation to Keep the Government Funded
12/01/2021 U.S. Senator Tina Smith & U.S. Representative Adam Schiff Introduce Bill to Expand Access to Lifesaving HIV Prevention Drugs
09/27/2021 Klobuchar, Wicker Introduce Bipartisan Legislation to Improve Treatment Courts
03/25/2021 Whitehouse, Portman, Capito, Klobuchar, Shaheen, Cantwell Introduce CARA 3.0 to Increase Access to Treatment, Prevention & Bolster Fight Against Addiction Epidemic
10/24/2018 Klobuchar's Bipartisan Bills to Combat the Opioid Epidemic Signed into Law
09/18/2018 Klobuchar's Bipartisan Bills to Crack Down on Synthetic Opioids Pass the Senate
05/25/2018 Klobuchar Bipartisan Legislation to Help Fight Synthetic Drugs Passes Senate Judiciary Committee
05/14/2018 Klobuchar Statement on Minnesota Department of Health Preliminary Report on Surge of Fentanyl-Involved Deaths in 2017
04/20/2018 Klobuchar, Collins Introduce Legislation to Support Community Prevention and Treatment Efforts for Low-Income Families Impacted by the Opioid Epidemic
04/20/2018 Klobuchar, Collins Introduce Legislation to Support Community Prevention and Treatment Efforts for Low-Income Families Impacted by the Opioid Epidemic
04/13/2018 Senators Collins, Klobuchar Introduce Bill to Authorize $50 Million Over Five Years for Community Organizations Responding to Opioid Addiction
04/12/2018 Klobuchar Highlights Efforts to Address the Dangers of Synthetic Drugs like Fentanyl at Judiciary Subcommittee Hearing
03/23/2018 Klobuchar Announces Congress Passes Major Funding to Combat the Opioid Epidemic
02/27/2018 Portman, Whitehouse, Capito, Klobuchar, Sullivan, Hassan, Cassidy & Cantwell Introduce CARA 2.0 Act
02/15/2018 Brown, Cornyn, Feinstein, Nelson, Klobuchar, Portman, Tillis, Ratcliffe, Rice Introduce Bill to Combat Drug-Facilitated Human Trafficking
11/01/2017 President's Commission on Combating Drug Addiction and the Opioid Crisis Includes Bipartisan Klobuchar Bills in Recommendations to the Administration
10/26/2017 Klobuchar Statement on Declaration of the Opioid Epidemic as a Public Health Emergency
09/08/2017 Klobuchar Statement on Report Showing Drug Overdose Deaths on the Rise in Minnesota
07/07/2017 Klobuchar Statement on Reports of Decline in Rate of Opioid Prescribing
07/03/2017 Klobuchar Presses Three Pharmaceutical Companies for Action on High Insulin Prices; Urges Vigilance Against Anticompetitive Conduct
06/26/2017 Klobuchar, Portman Call on the DEA to Provide Information to Support First Responders on the Frontlines in the Fight Against Synthetic Opioids
06/22/2017 Klobuchar, Bipartisan Group of Members of Senate Judiciary Committee Urge FDA Commissioner to Address Abuses in the Regulatory Process that Delay Competition and Increase Prescription Drug Costs
05/17/2017 Pro-Consumer Groups Announce Endorsement of Klobuchar's Legislation to Lower Prescription Drug Prices for Seniors
05/15/2017 Klobuchar, McCain, Grassley Urge OMB Director Mulvaney to Use Existing Executive Authority to Bring Down Prescription Drug Costs
04/28/2017 Klobuchar Outlines Minnesota Priorities for Federal Funds to Combat Opioid Crisis Ahead of National Take-Back Day

Page 1 of 5
arrow_upward